Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):363. doi: 10.1089/cap.2018.0012. Epub 2018 Apr 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antidepressive Agents / therapeutic use*
  • Child
  • Depressive Disorder, Major / drug therapy*
  • Desvenlafaxine Succinate / administration & dosage*
  • Fluoxetine / therapeutic use*
  • Humans
  • Psychopharmacology*
  • Research Design / standards*
  • Serotonin and Noradrenaline Reuptake Inhibitors / therapeutic use*

Substances

  • Antidepressive Agents
  • Serotonin and Noradrenaline Reuptake Inhibitors
  • Fluoxetine
  • Desvenlafaxine Succinate